|Bid||75.10 x 1100|
|Ask||75.20 x 1100|
|Day's range||73.88 - 75.52|
|52-week range||64.41 - 104.83|
|Beta (5Y monthly)||0.53|
|PE ratio (TTM)||11.50|
|Earnings date||06 Feb 2024 - 12 Feb 2024|
|Forward dividend & yield||2.66 (3.54%)|
|Ex-dividend date||19 Jan 2024|
|1y target est||87.23|
In this article, we will be taking a look at the 15 most expensive medical treatments/procedures in the US. To skip our detailed analysis, you can go directly to see the 5 most expensive medical treatments/procedures in the US. The U.S. is unique in that it is one of the only advanced countries in the […]
Shares of CVS Health (NYSE: CVS) rallied out of the gate on Wednesday morning, adding as much as 4.7%. The catalyst that sent the healthcare giant higher was bullish takes from a trio of Wall Street analysts. In the wake of the company's investor day on Tuesday, analysts are more bullish on the future prospects and the growing opportunity for CVS.
The way pharmacies in the United States make money is … kind of a mystery.